The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2017

Filed:

Apr. 27, 2009
Applicants:

Thomas F. Tedder, Durham, NC (US);

Koichi Yanaba, Tokyo, JP;

Jean-david Bouaziz, Limeil-brevannes, FR;

Inventors:

Thomas F. Tedder, Durham, NC (US);

Koichi Yanaba, Tokyo, JP;

Jean-David Bouaziz, Limeil-brevannes, FR;

Assignee:

Duke University, Durham, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C12N 5/00 (2006.01); A61K 35/17 (2015.01); C07K 16/28 (2006.01); C12N 5/0781 (2010.01); A61K 35/12 (2015.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); C07K 16/2887 (2013.01); C12N 5/0087 (2013.01); C12N 5/0635 (2013.01); A61K 2035/122 (2013.01); A61K 2035/124 (2013.01); A61K 2039/505 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C12N 2501/52 (2013.01);
Abstract

The present invention relates to a phenotypically distinct CD1dCD5B cell subset that regulates T cell mediated inflammatory responses through the secretion of interleukin-10 (IL-IO). The invention also relates to the use of these IL-IO producing regulatory B cells in the manipulation of immune and inflammatory responses, and in the treatment of disease. Therapeutic approaches involving adoptive transfer of these regulatory B cells, or expansion of their endogenous levels for controlling autoimmune or inflammatory diseases and conditions are described. Ablation of this subset of regulatory B cells, or inhibition of their IL-IO production can be used to upregulate immunodeficient conditions, and/or to treat tumors/cancer. Diagnostic applications also are encompassed.


Find Patent Forward Citations

Loading…